Le Lézard
Classified in: Health
Subjects: PDT, MAT

Physician Dr. Jay K Joshi releases a spellbinding book about his personal experiences through the opioid epidemic


CHICAGO, May 16, 2023 /PRNewswire/ -- Dr. Jay K Joshi, physician, author, entrepreneur, has released his debut book titled "Burden of Pain." The book presents a unique perspective on the opioid epidemic, arguably the most pressing health issues of our time.

Dr. John Whyte, Chief Medical Officer of WebMD, called it a "must-read for anyone affected by the opioid epidemic."

"Burden of Pain" is divided into two parts. The first part provides an account of Dr. Joshi's efforts to treat vulnerable patients in Northwest Indiana only to find himself at the crosshairs of the Drug Enforcement Agency and Department of Justice. 

The second part provides an analysis of the opioid epidemic, challenging current health policies and offers a new perspective on this complex issue. He uses principles from behavioral economics to show why most policies and guidelines fail to curtail rising overdoses.

The book combines his personal reflections about the opioid crisis with insights gleaned through his experiences. It provides a nuanced approach to thinking about patients with pain and physicians who treat them. It's a must-read for anyone affected by the opioid epidemic.

"Burden of Pain'' provides an opportunity for those affected by the opioid epidemic to find a voice for their sufferings. His experience reflects the darkest fears of any physician prescribing opioids for patients presenting with pain to the clinic encounter.

Dr. Joshi was indicted in 2018 for prescribing Norco 7.5/325mg BID outside the scope of medicine to an undercover DEA agent presenting with cramp-like leg pain. He has since regained his medical license and resumed his clinical practice. He was an amicus party to the Supreme Court case, Ruan v. United States, which established that convictions for physicians prescribing opioids illegally require criminal intent. 

"Burden of Pain" has received praise from notable medical professionals. Dr. John Whyte, Chief Medical Officer of WebMD, called it a "must-read for anyone affected by the opioid epidemic." Dr. Nabarun Dasgupta, Senior Scientist at UNC Injury Prevention and Research Center and advisor to the Center for Disease Control and Prevention, said the book "demonstrates the power of dedication to bettering the lives of patients."

For more information on "Burden of Pain" or to schedule time with Dr. Joshi, visit: www.burdenofpain.com .

To purchase a copy of "Burden of Pain", click the link: https://amzn.to/3Bqbmpl

SOURCE Dr. Jay K Joshi


These press releases may also interest you

at 15:30
The professional membership group of the American Hospital Association focused on healthcare marketing has enlisted experts from the advertising agency universe and the provider data sector to share insights about the best methods for reaching and...

at 15:20
Team famous for HIV breakthroughs demonstrates both persistent COVID virus and widespread immune activation in long COVID; provides clear targets for treatment Key points: SARS-CoV-2 double-stranded RNA indicative of viral replication was found in...

at 15:05
CloudMD Software & Services Inc. (the "Company" or "CloudMD"), an innovative health services company transforming the delivery of care, is pleased to announce that it has received a final order from the Supreme Court of British Columbia approving...

at 14:57
Workers at Watsonville Community Hospital represented by Teamsters Local 853 have voted unanimously to ratify a collective bargaining agreement. The new three-year contract includes significant wage increases, a strong benefits package with Teamsters...

at 14:55
The global anti-inflammatory therapeutics market size is estimated to grow by USD 38.7 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 6.3% during the forecast period. Increase in off-label use is...

at 14:45
Pulse Biosciences, Inc. (the "Company" or "Pulse Biosciences"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, announced today the closing of its rights offering and the final results...



News published on and distributed by: